SMARCA4 and cancer: Subsequent work determined that PFI-3 impaired both myoblastand preadipocyte differentiation [119].However, PFI-3 had no effect on cell proliferation in various human cancer celllines, perhaps because it failed to dislodge BRG1/BRM from chromatin [67,120].